Discontinuing cotrimoxazole preventive therapy in HIV-infected adults who are stable on antiretroviral treatment in Uganda (COSTOP): A randomised placebo controlled trial

BACKGROUND: Cotrimoxazole (CTX) preventive therapy (CPT) reduces opportunistic infections and malaria in HIV-infected patients. In Africa, policies on sustained CPT during antiretroviral therapy (ART) differ between countries. We assessed the safety of discontinuing CPT in stable patients on ART in...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:PLoS One
Autores principales: Anywaine, Zacchaeus, Levin, Jonathan, Kasirye, Ronnie, Lutaakome, Joseph Kayiira, Abaasa, Andrew, Nunn, Andrew, Grosskurth, Heiner, Munderi, Paula
Formato: Artigo
Lenguaje:Inglês
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6312229/
https://ncbi.nlm.nih.gov/pubmed/30596666
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0206907
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares